Search Results - "Borchiellini, D."

Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey by Barrière, J., Gal, J., Hoch, B., Cassuto, O., Leysalle, A., Chamorey, E., Borchiellini, D.

Get full text

Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab by Simonaggio, A., Elaidi, R., Fournier, L., Fabre, E., Ferrari, V., Borchiellini, D., Thouvenin, J., Barthelemy, P., Thibault, C., Tartour, E., Oudard, S., Vano, Y. A.

“…Background An elevated pre-treatment neutrophil to lymphocytes ratio (NLR) is associated with poor prognosis in various malignancies. Optimal cut-off is highly…”
Get full text

Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group by Guerin, M, Miran, C, Colomba, E, Cabart, M, Herrmann, T, Pericart, S, Maillet, D, Neuzillet, Y, Deleuze, A, Coquan, E, Laramas, M, Thibault, C, Abbar, B, Mesnard, B, Borchiellini, D, Dumont, C, Boughalem, E, Deville, J L, Cancel, M, Saldana, C, Khalil, A, Baciarello, G, Flechon, A, Walz, J, Gravis, G

“…Urachal cancer (UrC) is a rare, non-urothelial malignancy. Its natural history and management are poorly understood. Although localized to the bladder dome,…”
Get full text

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders by Boilève, A, Carlo, M I, Barthélémy, P, Oudard, S, Borchiellini, D, Voss, M H, George, S, Chevreau, C, Landman-Parker, J, Tabone, M-D, Chism, D D, Amin, A, Bilen, M A, Bosse, D, Coulomb-L'hermine, A, Su, Xiaoping, Choueiri, T K, Tannir, Nizar M, Malouf, Gabriel G

“…Microphthalmia Transcription Factor (MITF)family translocation renal cell carcinoma (tRCC) is a rare RCC subtype harboring TFE3/TFEB translocations. The…”
Get full text

18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns by Humbert, O., Cadour, N., Paquet, M., Schiappa, R., Poudenx, M., Chardin, D., Borchiellini, D., Benisvy, D., Ouvrier, M. J., Zwarthoed, C., Schiazza, A., Ilie, M., Ghalloussi, H., Koulibaly, P. M., Darcourt, J., Otto, J.

“…Purpose This prospective study aimed (1) to assess the non-small cell lung cancer (NSCLC) evolutive patterns to immunotherapy using FDG-PET and (2) to describe…”
Get full text

Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study by Saint, Angélique, Viotti, J., Borchiellini, D., Hoch, B., Raimondi, V., Hebert, C., Largillier, R., Evesque, L., Follana, P., Ferrero, J. M., Delaby, C., Schiappa, R., Chamorey, E., Barriere, J.

“…Purpose Anemia is common in oncology and negatively impacts quality of life. However, there is lack of knowledge about iron deficiency (ID) epidemiology. The…”
Get full text

Candidate apoptotic and DNA repair gene approach confirms involvement of ERCC1, ERCC5, TP53 and MDM2 in radiation-induced toxicity in head and neck cancer by Borchiellini, D, Etienne-Grimaldi, M.C, Bensadoun, R.J, Benezery, K, Dassonville, O, Poissonnet, G, Llorca, L, Ebran, N, Formento, P, Château, Y, Thariat, J, Milano, G

“…Highlights • The candidate-gene approach in HNSCC is relevant as few studies have investigated the topic. • Radiation-induced toxicity is a crucial point in…”
Get full text

Brain metastases response to nivolumab in patients with renal cell carcinoma (RCC): Prospective analysis from the GETUG-AFU 26 (NIVOREN) trial by Flippot, R., Dalban, C., Laguerre, B., Borchiellini, D., Gravis, G., Negrier, S., Chevreau, C.M., Joly, F., Geoffrois, L., Ladoire, S., Mahammedi, H., Tantot, F., Escudier, B., Albiges, L.

Get full text

Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse by Kinj, R., Doyen, J., Hannoun-Lévi, J.M., Naghavi, A.O., Chand, M.E., Baudin, G., Ferrero, J.M., François, E., Evesque, L., Borchiellini, D., Benezery, K., Bondiau, P.Y.

“…Up to 40% of patients who have received radiation for a pelvic malignancy will develop locoregional recurrence in the previously irradiated volume…”
Get full text

Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature by Borchiellini, D., Ghibaudo, N., Mounier, N., Del Giudice, P., Quinsat, D., Ticchioni, M., Perrin, C., Cardot Leccia, N., Lacour, J.P.

“…Background  Blastic plasmacytoid dendritic cell neoplasm (BPDCN), formerly known as agranular CD4+/CD56+ haematodermic neoplasm (CD4/CD56 HN), is a rare…”
Get full text

Analysis of Predictive Factors of Outcomes for Patient with Locally Advanced Unresectable Pharyngeal Squamous Cell Carcinoma (LAPSCC) Treated with Hyperfractionated Twice-daily Radiotherapy (HFRT) ± Cisplatin / Fluorouracil (BiRCF Trial) by Borchiellini, D, Benezery, K, Dassonville, O, Marcy, P.Y, Poissonnet, G, Chateau, Y, Etienne-Grimaldi, M.C, Peyrade, F, Bensadoun, R.J, Thariat, J

Get full text

Early death in older patients with cancer: risk factors of worse outcomes? by Boulahssass, R, Mari, V, Gonfrier, S, Auben, F, Abakar-Mahamat, A, Ludovic, E, Borchiellini, D, Brocker, P, Francois, E, Guerin, O

Get full text

CN54 Impact of the app-based and nurse-led supportive care program AKO@dom on dose-intensity of oral targeted therapies in patients with metastatic renal cell cancer: A multicentric observational retrospective study by Gaillard, V., Lhuillier, A., Bigot, C., Pierard, L., Trensz, P., Schuster, C., Malouf, G., Fritsch, A., Borchiellini, D., Geoffrois, L., Barthelemy, P.

Get full text

1762P MERINOS: Metastatic non muscle invasive urothelial carcinoma - An observational study by Haberstich, M., Pignot, G., Rigaud, J., Cancel, M., Maillet, D., Oudard, S., Pouessel, D., Serrate, C., Campedel, L., Dumont, C., Borchiellini, D., Barthelemy, P., Boughalem, E., Colomba, E., Huillard, O., Boyle, H.J., Lefort, F., Constans Schlurmann, F., Audenet, F., Thibault, C.

Get full text

A0841 - Delayed nephrectomy after immunotherapy for metastatic renal cell carcinoma: Oncological outcomes and predictive factors of surgical difficulties by Pignot, G., Margue, G., Bigot, P., Lang, H., Balssa, L., Roubaud, G., Borchiellini, D., Bensalah, K., Schlürmann, F., Ladoire, S., Parier, B., Bernhard, J.C., Cassuto, O., Albiges, L., Thibault, C., Ingels, A., Cherifi, F., Waeckel, T., Walz, J., Flippot, R., Geoffrois, L., Gravis, G., Barthelemy, P.

Get full text

Delayed nephrectomy after immunotherapy for metastatic renal cell carcinoma: Oncological outcomes and predictive factors of surgical difficulties by Pignot, G., Margue, G., Bigot, P., Lang, H., Balssa, L., Roubaud, G., Borchiellini, D., Bensalah, K., Schlürmann, F., Ladoire, S., Parier, B., Bernhard, J.C., Cassuto, O., Albiges, L., Thibault, C., Ingels, A., Cherifi, F., Waeckel, T., Walz, J., Flippot, R., Geoffrois, L., Gravis, G., Barthelemy, P.

Get full text

2364MO Durvalumab (D) +/- tremelimumab (T) in combination with dose-dense MVAC (ddMVAC) as neoadjuvant treatment in patients with muscle-invasive bladder carcinoma (MIBC): Results of NEMIO, a randomized phase I-II trial by Thibault, C., Bennamoun, M., Flechon, A., Gravis, G., Pouessel, D., Combe, P-F., Borchiellini, D., Loriot, Y., Laguerre, B., Barthelemy, P., Gross Goupil, M., Helissey, C., Huillard, O., Cancel, M., Campedel, L., Audenet, F., Belhouari, H., Kotti, S., Tran, Y., Oudard, S.

Get full text

1691P Evaluation of practice variation for cancer patients care in a French cancer center during the COVID-19 outbreak by Borchiellini, D., Hannoun-Levi, J-M., Gal, J., Gosset, M., Besrest, E., Francois, E., Pilato, A., Ferrero, J-M., Barranger, E.

Get full text

1059P NEMIO: A randomized phase I-II trial evaluating efficacy and safety of dose dense MVAC (ddMVAC) + durvalumab +/- tremelimumab as neoadjuvant treatment in patients with bladder muscle-invasive urothelial carcinoma by Thibault, C., Elaidi, R.T., Pouessel, D., Fléchon, A., Borchiellini, D., Barthélémy, P., Huillard, O., Rouabah, M., Braychenko, E., Helali, I., Audenet, F., Oudard, S.

Get full text

Online public interest in urological cancers during the Covid-19 pandemic: What can “Dr. Google” teach us? by Khene, Z-E., Guérin, S., Khene, F., Pradère, B., Roumiguié, M., Mathieu, R., Albiges, L., Borchiellini, D., Pignot, G., Neuzillet, Y., Ploussard, G., Bigot, P., De La Taille, A., Rouprêt, M., Bensalah, K.

Get full text